2000 SIERRA POINT PARKWAY, BRISBANE, CA
Submission of Matters to a Vote of Security Holders
Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
Warrant Exercise Agreement with Holder for Tempest Therapeutics, Inc.
Director Resignation - Ms. Simantov Steps Down from Tempest Therapeutics Board
Director Resignations - Stephen Brady, Michael Raab, and Christine Pellizzari
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Reports First Quarter 2026 Financial Results and Provides Business Update
Developing Advanced Therapies for Cancer Patients
Q1
FY 2025
Q3
Q2
Amended Annual Report
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
PRE 14A
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Amended Schedule 13D - Ownership Report
S-8 POS
Correspondence
Submission Upload